{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:03:38Z","timestamp":1788869018506,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","award":["09120012110011"],"award-info":[{"award-number":["09120012110011"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.nucmedbio.2025.109055","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T22:56:10Z","timestamp":1754520970000},"page":"109055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Characterization of [11C]DASB and [18F]FE-PE2I using microPET imaging in SERT and DAT knockout rats"],"prefix":"10.1016","volume":"148-149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2312-5570","authenticated-orcid":false,"given":"Cyprien G.J.","family":"Guerrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie R.M.","family":"Tesselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile E.","family":"Zweistra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cabiscol-Claveria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bieneke","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Doorduin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnt F.A.","family":"Schellekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith R.","family":"Homberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2025.109055_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41398-021-01771-3","article-title":"Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders","volume":"12","author":"Cabana-Dom\u00ednguez","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9020109","article-title":"Dopamine in health and disease: much more than a neurotransmitter","volume":"9","author":"Franco","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.9758\/cpn.2014.12.3.196","article-title":"Serotonin and mental disorders: a concise review on molecular neuroimaging evidence","volume":"12","author":"Lin","year":"2014","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2215-0366(15)00232-1","article-title":"The serotonin transporter in psychiatric disorders: insights from PET imaging","volume":"2","author":"Spies","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0025","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1038\/s41380-019-0618-7","article-title":"Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study","volume":"26","author":"Hjorth","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0030","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hbm.23418","article-title":"Altered interregional molecular associations of the serotonin transporter in attention deficit\/hyperactivity disorder assessed with PET","volume":"38","author":"Vanicek","year":"2017","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13550-023-00974-7","article-title":"[18F]FE-PE2I DAT correlates with Parkinson\u2019s disease duration, stage, and rigidity\/bradykinesia scores: a PET radioligand validation study","volume":"13","author":"Kerstens","year":"2023","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12149-013-0798-1","article-title":"Age-related decline in dopamine transporter in human brain using PET with a new radioligand [18F]FE-PE2I","volume":"28","author":"Shingai","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0969-8051(02)00316-5","article-title":"In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography","volume":"29","author":"Wilson","year":"2002","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0050","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/syn.20670","article-title":"In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand","volume":"63","author":"Varrone","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0055","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1021\/jm000079i","article-title":"Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines","volume":"43","author":"Wilson","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0060","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s002590000365","article-title":"Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB","volume":"27","author":"Houle","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0065","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/BF01271252","article-title":"Rat strain differences in the vulnerability of serotonergic nerve endings to neurotoxic damage by p-chloroamphetamine","volume":"103","author":"Zhou","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0070","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.neuroscience.2007.03.030","article-title":"Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system","volume":"146","author":"Homberg","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0075","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.1931-17.2018","article-title":"Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats","volume":"38","author":"Leo","year":"2018","journal-title":"J Neurosci"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jlcr.2927","article-title":"An efficient one-step radiosynthesis of [18F]FE-PE2I, a PET radioligand for imaging of dopamine transporters","volume":"55","author":"Stepanov","year":"2012","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0085","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.nucmedbio.2015.11.002","article-title":"PET imaging of dopamine transporters with [18F]FE-PE2I: effects of anti-Parkinsonian drugs","volume":"43","author":"Bang","year":"2016","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106727","article-title":"Increased dopamine D2\/D3 receptor and serotonin transporter availability in male rats after spontaneous remission from repeated social defeat-induced depression; a PET study in rats","volume":"202","author":"Moraga-Amaro","year":"2024","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0095","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2967\/jnumed.114.147488","article-title":"123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo","volume":"56","author":"Bakker","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2967\/jnumed.110.077651","article-title":"Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with 11C-PE2I and 18F-FE-PE2I","volume":"52","author":"Varrone","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109055_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0006-8993(99)02018-1","article-title":"Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain","volume":"849","author":"Tsukada","year":"1999","journal-title":"Brain Res"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:11:20Z","timestamp":1774962680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805125000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":21,"alternative-id":["S0969805125000642"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109055","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of [11C]DASB and [18F]FE-PE2I using microPET imaging in SERT and DAT knockout rats","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109055"}}